Use of medication for challenging behaviour in people with intellectual disability.

Gyles Glover Sarah Bernard David Branford Anthony Holland Andre Strydom

Br J Psychiatry

Gyles Glover, MSc, MD, FRCPsych, FPPH, Co-Director, Learning Disabilities Team, Public Health England; Sarah Bernard, MD, FRCPsych, DRCOG, Child and Adolescent Learning Disability Service, South London and Maudsley NHS Foundation Trust; David Branford, PhD, FRPharmS, FCMHP, Chairman, English Pharmacy Board, Royal Pharmaceutical Society; Anthony Holland, MPhil, MRCP, FRCPsych, Diploma in Clinical Genetics, Health Foundation Chair in Learning Disabilities, Academic Department of Psychiatry, University of Cambridge; Andre Strydom, MSc, PhD, MRCPsych, Reader in Intellectual Disabilities, Mental Health Sciences Unit, University College London, UK.

Published: July 2014

Download full-text PDF	Source
http://dx.doi.org/10.1192/bjp.bp.113.141267	DOI Listing

Publication Analysis

Top Keywords

medication challenging

challenging behaviour

behaviour people

people intellectual

intellectual disability

medication

behaviour

people

intellectual

disability

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!